Publikationen in Zeitschriften mit Gutachtersystem

 

 

1 9 9 3

 

1. S. Roßner, W. Kues, V. Witzemann, R. Schliebs (1993) Laminar expression of m1-, m3-, and m4-muscarinic cholinergic receptor genes in the developing rat visual cortex using in situ hybridization histochemistry. Effect of monocular visual deprivation. Int. J. Devl. Neurosci. 11, 369-378. IF: 1,9

 

2. S. Roßner, A. Kumar, W. Kues, V. Witzemann, R. Schliebs (1993) Differential laminar expression of AMPA receptor genes in the developing rat visual cortex using in situ hybridization histochemistry. Effect of visual deprivation. Int. J. Devl. Neurosci. 11, 411-424. IF: 1,9

 

1 9 9 4

 

3. S. Roßner, A. Kumar, V. Witzemann, R. Schliebs (1994) Development of laminar expression of the m2 muscarinic cholinergic receptor gene in rat visual cortex and the effect of monocular visual deprivation. Dev. Brain Res. 77, 55-61; Erratum 78, 296-297. IF: 1,8

 

4. R. Schliebs, S. Roßner, A. Kumar, V. Bigl (1994) Muscarinic acetylcholine receptor subtypes in rat visual cortex - a comparative study using quantitative receptor autoradiography and in situ hybridization. Indian J. Exper. Biol. 32, 25-30. IF: 0,7

 

5. R. Schliebs, T. Feist, S. Roßner, V. Bigl (1994) Receptor function in cortical rat brain regions after lesion of Nucleus Basalis. J. Neural Transm. (Gen. Section), Suppl. 44, 195-208. IF: 2,6

 

6. S. Roßner, R. Schliebs, V. Bigl (1994) Ibotenic acid lesion of nucleus basalis magnocellularis differentially affects cholinergic, glutamatergic, and GABAergic markers in cortical rat brain regions. Brain Res. 668, 85-99. IF: 2,6

 

7. S. Roßner, J.R. Perez-Polo, R.G. Wiley R. Schliebs, V. Bigl (1994) Differential expression of immediate early genes in distinct layers of rat cerebral cortex after selective immunolesion of the forebrain cholinergic system. J. Neurosci. Res. 38, 282-293. IF: 3,0

 

1 9 9 5

 

8. S. Roßner, R. Schliebs, J.R. Perez-Polo, R.G. Wiley, V. Bigl (1995) Differential changes in cholinergic markers from selected brain regions after specific immunolesion of rat cholinergic basal forebrain system. J. Neurosci. Res. 40, 31-43. IF: 3,0

 

9. S. Roßner, W. Härtig, R. Schliebs, G. Brückner, K. Brauer, J.R. Perez-Polo, R.G. Wiley, V. Bigl (1995) 192IgG-saporin immunotoxin-induced loss of cholinergic cells differentially activates microglia in rat basal forebrain nuclei. J. Neurosci. Res. 41, 335-346. IF: 3,0

 

10. S. Roßner, R. Schliebs, W. Härtig, V. Bigl (1995) 192IgG-saporin-induced immunotoxic lesion of cholinergic basal forebrain system: neurochemical effects on cholinergic neurotransmission in rat cerebral cortex and hippocampus. Brain Res. Bull. 38, 371-381. IF: 2,5

 

11. S. Roßner, R. Schliebs, V. Bigl (1995) 192IgG-saporin-induced immunotoxic lesions of cholinergic basal forebrain system differentially affect glutamatergic and GABAergic markers in cortical rat brain regions. Brain Res. 696, 165-176. IF: 2,6

  

1 9 9 6

 

12. S. Roßner, J. Yu, D. Pizzo, K. Werrbach-Perez, R. Schliebs, V. Bigl, J.R. Perez-Polo (1996) Effects of intraventricular transplantation of NGF-secreting cells on basal forebrain cholinergic neurons after partial immunolesion. J. Neurosci. Res. 45, 40-56. IF: 3,0

 

13. R. Schliebs, S. Roßner, V. Bigl (1996) Immunolesion by 192IgG-saporin of rat basal forebrain cholinergic system: a useful tool to produce cortical cholinergic dysfunction. Progr. Brain Res. 109, 253-264. IF: 3,1

  

1 9 9 7

 

14. S. Roßner (1997) Cholinergic immunolesions by 192IgG-saporin - a useful tool to simulate pathogenic aspects of Alzheimer’s disease. Int. J. Devl. Neurosci. 15, 835-850. IF: 1,9

 

15. S. Roßner, G. Wörtwein, J. Yu, Z. Gu, R. Schliebs, V. Bigl, J.R. Perez-Polo (1997) Cholinergic control of nerve growth factor in adult rats - evidence from cortical cholinergic deafferentation and chronic drug treatment. J. Neurochem. 69, 947-953. IF: 4,3

 

16. S. Roßner, R. Schliebs, W. Härtig, J.R. Perez-Polo, V. Bigl (1997) Selective induction of c-Jun and NGF in reactive astrocytes after cholinergic degenerations in rat basal forebrain. NeuroReport 8, 2199-2202. IF: 1,8

 

17. S. Roßner, U. Ueberham, J. Yu, L. Kirazov, R, Schliebs, R. Perez-Polo, V. Bigl (1997) In vivo regulation of amyloid precursor protein secretion in rat neocortex by cholinergic activity. Eur. J. Neurosci. 9, 2125-2134. IF: 3,7

 

18. G. Seeger, W. Härtig, S. Roßner, R. Schliebs, G. Brückner, V. Bigl, K. Brauer (1997) Electron microscopic evidence for microglial phagocytic activity and cholinergic cell death after administration of the immunotoxin 192IgG-saporin in rat. J. Neurosci. Res. 48, 465-476. IF: 3,0

 

19. M. Heider, R. Schliebs, S. Roßner, V. Bigl (1997) Basal forebrain cholinergic immnunolesion by 192IgG-saporin: evidence for a presynaptic location of subpopulations ofa2- andb-adrenergic as well as 5-HT2A receptors on cortical cholinergic terminals. Neurochem. Res. 22, 957-966. IF: 2,6

 

20. J. Apelt, R. Schliebs M. Beck, S. Roßner, V. Bigl (1997) Expression of amyloid precursor protein mRNA isoforms in rat brain is differntially regulated during postnatal maturation and by cholinergic activity. Int. J. Devl. Neurosci. 15, 95-112. IF: 1,9

 

21. M.K. Brückner, S. Roßner, T. Arendt (1997) Differential changes in the expression of AMPA receptor genes in rat brain after chronic exposure to ethanol: an in situ hybridization study. J. Brain Res. 38, 369-376. IF: 0,7

  

1 9 9 8

 

22. S. Roßner, U. Ueberham, R. Schliebs, J. R. Perez-Polo, V. Bigl (1998) The regulation of APP metabolism by cholinergic mechanisms and neurotrophin receptor signaling. Progr. Neurobiol. 56, 541-569. IF: 10,0

 

23. S. Roßner, U. Ueberham, R. Schliebs, J.R. Perez-Polo, V. Bigl (1998) Neurotrophin binding to the p75 neurotrophin receptor is required but not sufficient to mediate NGF-effects on APP secretion in PC-12 cells. J. Neural Transm. Suppl.54, 279-285. IF: 2,6

 

24. S. Roßner, U. Ueberham, R. Schliebs, J.R. Perez-Polo, V. Bigl (1998) p75NTR and TrkA receptor signaling independently regulate APP mRNA expression, isoform composition, and protein secretion in PC-12 cells. J. Neurochem. 71, 757-766. IF: 4,3

 

25. S. Roßner, N. Bakinde, U. Zeitschel, R. Schliebs, V. Bigl (1998) Cerebrospinal fluid cholinesterases - Markers for loss of cholinergic basal forebrain neurons? Int. J. Devl. Neurosci. 16, 669-673. IF: 1,9

 

26. G. Mehlhorn, T. Löffler, J. Apelt, S. Roßner, T. Urabe, N. Hattori, S. Nagamatsu, V. Bigl, R. Schliebs (1998) Glucose metabolism in cholinoceptive cortical rat brain regions after basal forebrain cholinergic lesion. Int. J. Devl. Neurosci. 16, 675-690. IF: 1,9

 

27. K. Brauer, G. Seeger, W. Härtig, S. Roßner, R. Poethke, R. Schliebs, G. Brückner, V. Bigl (1998) Electron microscopic evidence for a cholinergic innervation of GABAergic parvalbumin-immunoreactive neurons in the rat medial septum. J. Neurosci. Res. 54, 248-253. IF: 3,0

 

28. R. Lemke, W. Härtig, S. Roßner, V. Bigl, R. Schliebs (1998) Interleukin-6 is not expressed in activated microglia and in reactive astrocytes in response to lesion of rat basal forebrain cholinergic system as demonstrated by combined in situ hybridization and immunocytochemistry. J. Neurosci. Res. 51, 223-236. IF: 3,0

 

29. R.M. Nitsch, S. Roßner, C. Albrecht, M. Mayhaus, J. Endrich, R. Schliebs, M. Wegner, T. Arendt, H. von der Kammer (1998) Muscarinic acetylcholine receptors activate acetylcholinesterase gene promoter. J. Neurophysiol. 92, 257-264. IF: 3,1

  

1 9 9 9

 

30. S. Roßner, R. Schliebs, V. Bigl (1999) Regulation of amyloid precursor protein catabolism by cholinergic mechanisms. Alzheimer Actualites 143, 8-13.

 

31. S. Roßner, U. Ueberham, R. Schliebs, J.R. Perez-Polo, V. Bigl (1999) Regulated secretion of amyloid precursor protein by TrkA receptor stimulation is mitogen activated protein kinase sensitive. Neurosci. Lett. 271, 97-100. IF: 2,0

 

32. R. Lemke, S. Roßner, R. Schliebs (1999) Leukemia inhibitory factor expression is not induced in activated microglia and reactive astrocytes in response to rat basal forebrain cholinergic lesion. Neurosci. Lett. 267, 53-56. IF: 2,0

 

33. D. Sorger, I. Kämpfer, R. Schliebs, S. Roßner, C. Dannenberg, W.H. Knapp (1999) Iodo-QNB cortical binding and brain perfusion: effects of a cholinergic basal forebrain lesion in the rat.  Nucl. Med. and Biology 26, 9-16. IF: 2,6

 

34. E. Reisner, M. Nöldner, S. Roßner, S.S. Chatterjee, V. Bigl, R. Schliebs (1999) Acute effect of KA-672, a putative cognitive enhancer, on neurotransmitter receptor binding in mouse brain. Neurosci. Lett. 274, 187-190. IF: 2,0

 

2 0 0 0

 

35. S. Roßner, M. Beck, T. Stahl, K. Mendla, R. Schliebs, V. Bigl (2000) Constitutive overactivation of protein kinase C in guinea pig brain increasesa-secretory APP processing without decreasingb-amyloid generation. Eur. J. Neurosci. 12, 3191-3200.IF: 3,7 

 

36. S. Roßner, R. Schliebs, V. Bigl (2000) Intracerebroventricular infusion of CHO5, a rat monoclonal antibody directed against mouse low-affinity nerve growth factor receptor (p75NTR), specifically labels basal forebrain cholinergic neurons in mouse brain. Metab. Brain Disease 15, 17-27. IF: 2,3

 

37. D. Sorger, R. Schliebs, I. Kämpfer, S. Roßner, J. Heinicke, C. Dannenberg, P. Georgi (2000) In vivo [125I]-iodobenzovesamicol binding reflects cortical cholinergic deficiency induced by specific immunolesion of rat basal forebrain cholinergic system.  Nucl. Med. and Biology 27, 23-31. IF: 2,6

 

38. M. Bigl, J. Apelt, E. Luschekina, C. Lange-Dohna, S. Roßner, R. Schliebs (2000) Expression ofb-secretase mRNA in transgenic Tg2576 mouse brain with Alzheimer plaque pathology. Neurosci. Lett. 292, 107-110. IF: 2,0

  

2 0 0 1

 

39. S. Roßner, G. Mehlhorn, R. Schliebs, V. Bigl (2001) Increased neuronal and glial expression of protein kinase C isoforms in neocortex of transgenic Tg2576 mice with amyloid pathology. Eur. J. Neurosci. 13, 269-278. IF: 3,7

 

40. S. Roßner, K. Mendla, R. Schliebs, V. Bigl (2001) Protein kinase Caandb1 isoforms are regulators ofa-secretory proteolytic processing of amyloid precursor protein in vivo. Eur. J. Neurosci. 13, 1644-1648.IF: 3,7

 

41. S. Roßner, M.K. Brückner, V. Bigl (2001) Developmentally induced microencephalopathy in guinea pigs - embryonic glial cell activation marks selective neuronal death. Int. J. Devl. Neurosci. 19, 313-318. IF: 1,9

 

42. S. Roßner, J. Apelt, R. Schliebs, J.R. Perez-Polo, V. Bigl (2001) Neuronal and glialb-secretase (BACE) protein expression in transgenic Tg2576 mice with amyloid plaque pathology. J. Neurosci. Res. 64, 437-446. IF: 3,0

 

2 0 0 2

 

43. U. Zeitschel, R. Schliebs, S. Roßner, V. Bigl, K. Eschrich, M. Bigl (2002) Changes in activity and expression of phosphofructokinase in different rat brain regions after basal forebrain cholinergic lesion. J. Neurochem. 83, 371-380. IF: 4,3

  

2 0 0 3

 

44. M. Hartlage-Rübsamen, U. Zeitschel, J. Apelt, U. Gärtner, H. Franke, T. Stahl, A. Günther, R. Schliebs, M. Penkowa, V. Bigl, S. Roßner (2003) Astrocytic expression of the Alzheimer’s diseaseb-secretase (BACE) is stimulus-dependent. Glia 41, 169-179. IF: 5,2

 

45. C. Lange-Dohna, U. Zeitschel, F. Gaunitz, R. Perez-Polo, V. Bigl, S. Roßner (2003) Cloning and expression of the rat BACE1 promoter. J. Neurosci. Res. 73, 73-80. IF: 3,0

 

46. M. Beck, V. Bigl, S. Roßner (2003) Guinea pigs as a nontransgenic model for APP processing in vitro and in vivo. Neurochem. Res. 28, 637-644. IF: 2,6

 

47. M. Tomaszewicz, S. Roßner, R. Schliebs, J. Ewikowska, A. Szutowicz (2003) Changes in cortical acetyl-CoA metabolism after selective basal forebrain cholinergic degeneration by 192IgG-saporin. J. Neurochem. 87, 318-324. IF: 4,3

 

48. V. Bigl and S. Roßner (2003) Amyloid precursor protein processing in vivo - insights from a chemically-induced constitutive overactivation of protein kinase C in guinea pig brain. Curr. Med. Chem. 10, 871-882. IF: 4,6

  

2 0 0 4

 

49. S. Roßner, K. Fuchsbrunner, C. Lange-Dohna, M. Hartlage-Rübsamen, V. Bigl, A. Betz, K. Reim, N. Brose (2004) Munc13-1-mediated vesicle priming contributes to secretory APP processing.J. Biol. Chem. 279, 27841-27844. IF: 5,3

 

50. H. Franke, A. Günther, J. Grosche, R. Schmidt, S. Roßner, R. Reinhardt, H. Faber-Zuschratter, D. Schneider, P. Illes (2004).P2X7 receptor expression after ischemia in the cerebral cortex of rats. J. Neuropathol. Exp. Neurol. 63, 686-699.IF: 4,2

 

51. S. Roßner (2004) New players in old amyloid precursor protein processing pathways. Int. J. Dev. Neurosci. 22, 467-474. IF: 1,9

  

2 0 0 5

 

52. S. Roßner, C. Lange-Dohna, -secretase BACE1 is notbU. Zeitschel, R. Perez-Polo (2005) Alzheimer’s disease  a neuron-specific enzyme. J. Neurochem. 92, 226-234. IF: 4,3

 

53. I. Schulz, U. Zeitschel, T. Rudolph, D. Ruiz-Carrillo, J.-U. Rahfeld, B. Gerhartz, V. Bigl, H.-U. Demuth, S. Roßner (2005) Subcellular localization suggests novel functions for prolyl endopeptidase in protein secretion. J. Neurochem.94,970-979.  IF: 4,3 

 

54. S. Roßner, I. Schulz, U. Zeitschel, R. Schliebs, V. Bigl, H.-U. Demuth (2005) Brain prolyl endopeptidase expression in aging, APP transgenic mice and Alzheimer’s disease. Neurochem. Res.30,695-702.IF: 2,6

 

55. A. Günther, L. Küppers-Tiedt, P.-M. Schneider, I. Kuhnert, J. Berrouschot, D. Schneider, S. Roßner (2005) Differential effects on glial cell activation of hyperbaric oxygen treatment in permanent focal cerebral ischemia of rats. Eur. J. Neurosci.21,3189-3194.IF: 3,7

 

56. C. Hobohm, A. Günther, J. Grosche, S. Roßner, D. Schneider, G. Brückner (2005) Decomposition and long-lasting downregulation of extracellular matrix in perineuronal nets induced by focal forebrain ischemia. J. Neurosci. Res. 80, 539-548. IF: 3,0

 

2 0 0 6

 

57. M. Sastre, I. Dewachter, S. Roßner, N. Bogdanovic, E. Rosen, P. Borghgraef, B. Evert, L. Dumitrescu-Ozimek, D. Thal, G. Landreth, J. Walter, T. Klockgether, F. van Leuven, M.T. Heneka (2006) NSAIDs repress BACE1 gene promoter activity by activation of the peroxisome proliferator–activated receptor-g(PPARg). Proc. Natl. Acad. Sci. USA103,443-448.IF: 9,8

 

58. K. Nowak, C. Lange-Dohna, U. Zeitschel, A. Günther, B. Lüscher, A. Robitzki, R. Perez-Polo, S. Roßner (2006) The transcription factor Yin Yang1 is an activator of BACE1 expression. J. Neurochem. 96, 1696-1707. IF: 4,3

 

59. S. Roßner, M. Sastre, K.Z. Bourne, S. Lichtenthaler (2006) Transcriptional and translational regulation of BACE1 expression – implications for Alzheimer’s disease. Progr. Neurobiol. 79, 95-111. IF: 10,0

  

2 0 0 7

 

60. S. Reimers, M. Hartlage-Rübsamen, G. Brückner, S. Roßner (2007) Formation of perineuronal nets in organotypic mouse brain slice cultures is independent of neuronal glutamatergic activity. Eur. J. Neurosci. 25, 2640-2648. IF: 3,7

 

61. K.Z. Bourne, D.C. Ferrari, C. Lange-Dohna, S. Roßner, T.G. Wood, J.R. Perez-Polo (2007) Differential regulation of BACE1 promoter activity by nuclear factor-kB in neurons and glia upon exposure tob-amyloid peptides.J. Neurosci. Res.85,1194-1204. IF: 3,0

 

62. D. Milius, D. Stanchev, C. Lange-Dohna, S. Roßner, K. Wirkner, P. Illes (2007) Oxygen/glucose deprivation increase the integration of recombinant P2X7 receptors in the plasma membrane of HEK293 cells. Toxicology 238, 60-69. IF: 3,6

  

2 0 0 8

 

63. H.-J. Schneider, S. Roßner, D. Pfeiffer, A. Hagendorff (2008) D-ribose improves cardiac contractility and hemodynamics, and reduces expression of c-fos in the hippocampus during sustained slow ventricular tachycardia in rats. Int. J. Cardiol. 125, 49-56. IF: 6,8

 

64. V. Buggia-Prevot, J. Sevalle, S. Roßner, F. Checler (2008) NF-kB-dependent control of BACE1 promoter transactivation by Abeta42. J. Biol. Chem. 283, 10037-10047. IF: 5,3

 

65.S. Schilling, U. Zeitschel, T. Hoffmann, U. Heiser, M. Francke, A. Kehlen, M. Holzer, B. Hutter-Paier, M. Prokesch, M. Windisch, W. Jagla, D. Schlenzig, C. Lindner, T. Rudolph, G. Reuter, H. Cynis, D. Montag,H.-U. Demuth, S. Roßner (2008) Glutaminyl cyclase inhibition attenuates pyroglutamate Abeta and Alzheimer’s disease-like pathology.Nat. Med.14, 1106-1111. IF: 25,4

  

2 0 0 9

 

66. A. Hoffmeister, G. Dietz, U. Zeitschel, J. Mössner, S. Roßner, T. Stahl (2009) BACE1 is a new pancreatic secreted protein that cleaves enteropeptidase in vitro. J. Pancreas 10,501-506.

 

67. M Hartlage-Rübsamen, K. Staffa, A. Waniek, M. Wermann, T. Hoffmann, H. Cynis, H.-U. Demuth, S. Roßner (2009) Developmental expression and subcellular localization of glutaminyl cyclase in mouse brain. Int. J. Dev. Neurosci. 27, 825-835. IF: 2,7

  

2 0 1 0

 

68.S. Mitterreiter, R.M. Page, F. Kamp, J. Hopson, E. Winkler, H.-R. Ha, R. Hamid, J. Herms, T.U. Mayer, D.J. Nelson, H. Steiner, U. Zeitschel, T. Stahl, S. Roßner, C. Haass, S.F. Lichtenthaler (2010) Bepridil and amiodarone simultaneously target the -secretase via distinct mechanisms.g- and bAlzheimer’s disease  J. Neurosci. 30, 8974-8983.IF: 7,3

 

69. M. Morawski, M. Hartlage-Rübsamen, C. Jäger, A. Waniek, S. Schilling, C. Schwab, P. McGeer, T. Arendt, H.U. Demuth, S. Roßner (2010)Distinct glutaminyl cyclase expression in Edinger-Westphal bnucleus, locus coeruleus and nucleus basalis Meynert contributes to pGlu-A pathology in Alzheimer’s disease. Acta Neuropathol.120,195-207.IF: 9,7

 

70. P.H. Kuhn, H. Wang, B. Dislich, A. Colombo, U. Zeitschel, J.W. Ellwart, E. Kremmer, S. Roßner, S.F. Lichtenthaler (2010) ADAM10 is the physiologically relevant, constitutive alpha-secretase of the amyloid precursor protein in primary neurons. EMBO J. 29, 3020-3032. IF: 10,1

 

 2 0 1 1

 

71. M. Hartlage-Rübsamen, M. Morawski, A. Waniek, C. Jäger, U. Zeitschel, B. Koch, H. Cynis, S. Schilling, R. Schliebs, H.U. Demuth, S. Roßner (2011) Glutaminyl cyclase contributes to the formation of focal and diffuse pyroglutamate (pGlu)-Abdeposits in hippocampus via distinct cellular mechanisms. Acta Neuropathol. 121, 705-719. IF: 9,7

 

72. S. Schilling, S. Kohlmann, C. Bäuscher, R. Sedlmeier, B. Koch, R. Eichentopf, A. Becker, H. Cynis, T. Hoffmann, S. Berg, E.J. Freyse, S. von Hörsten, S. Roßner, S. Graubner, H.U. Demuth (2011) Glutaminyl cyclase (QC) knock-out mice show mild hypothyreodism but absence of hypogonadism: implications for enzyme function and drug development. J. Biol. Chem.286,14199-14208.IF: 5,3

 

73. M. Morawski, I. Schulz, U. Zeitschel, M. Blosa, G. Seeger, S. Roßner (2011) Role of prolyl oligopeptidase in intracellular transport and protein secretion. CNS & Neurological Disorders - Drug Targets 10, 327-332.IF: 3,6

 

74. A. Penttinen, J. Tenorio-Laranga, A. Siikanen, M. Morawski, S. Roßner, J.A. García-Horsman (2011) Prolyl oligopeptidase: a rising star on the stage of neuroinflammation research. CNS & Neurological Disorders - Drug Targets 10, 340-348.IF: 3,6

 

75.  A. Alexandru, W. Jagla, S. Graubner, A. Becker, C. Bäuscher, S. Kohlmann, R. Sedlmeier, K.A. Raber, H. Cynis, R. Rönicke, K.G. Reymann, E. Petrasch-Parwez, M. Hartlage-Rübsamen, A. Waniek, S. Roßner, S. Schilling, A.P. Osmand, H.U. Demuth, S. von Hörsten (2011) Selective hippocampal  ibneurodegeneration in transgenic mice expressing small amounts of truncated As  formation.binduced by pyro-Glu-AJ. Neurosci. 31,12790-12801. IF: 7,3

 

76. I. Schulz, C. Engel, A.J. Niestroj, U. Zeitschel, K. Menge, A. Kehlen, A. Meyer, S. Roßner,H.U. Demuth (2011) Heteroarylketones inhibit astroglial interleukin-6 expression via a STAT3/NF-kB signaling pathway. J. Neuroinflamm. 8, 86. IF: 5,8 

 

2 0 1 2

 

77. P.H. Kuhn, K. Koroniak, S. Hogl, A. Colombo, U. Zeitschel, M. Willem, C. Vollbracht, U. Schepers, A. Imhof, A. Hoffmeister, C. Haass, S. Roßner, S. Bräse, S.F. Lichtenthaler (2012) Secretome protein enrichment identifies physiological BACE1 substrates in neurons. EMBO J. 31, 3157-3168.IF: 10,1

  

2 0 1 3

 

78. M. Hartlage-Rübsamen, A. Waniek, S. Roßner (2013)Munc13 genotype regulates secretory amyloid precursor protein processing via postsynaptic glutamate receptors. Int. J. Devl. Neurosci. 31, 36-45.IF: 2,7

 

79. M. Morawski, K. Nuytens, T. Juhasz, U. Zeitschel, G. Seeger, E. Waelkens, L. Regal, I. Schulz, T. Arendt, Z. Szeltner, J. Creemers, S. Roßner (2013) Cellular and ultra structural evidence forcytoskeletal localization of prolyl endopeptidase-like protein in neurons.Neuroscience242,128-139. IF: 3,1

 

80. A. Hoffmeister, J. Tuennemann, I. Sommerer, J. Mössner, A. Rittger, D. Schleinitz, J. Kratzsch, J. Rosendahl, N. Klöting, T. Stahl, S. Roßner, F. Paroni, K. Maedler, P. Kovacs, M. Blüher (2013) Genetic and biochemical evidence for a functional role of BACE1 in the regulation of insulin mRNA expression. Obesity 21, E 626-633. IF: 3,9

  

2 0 1 4

  

81.  M. Morawski, S. Schilling, M. Kreuzberger, A. Waniek, C. Jäger, B. Koch, H. Cynis, A. Kehlen, T. Arendt, M. Hartlage-Rübsamen, H.U. Demuth, S. Roßner (2014) Glutaminyl cyclases in human cortex – Correlation with (pGlu)-Abeta load and cognitive decline in Alzheimer’s disease. J. Alzh. Dis. 39(2), 385-400. IF: 4,2

 

82. I. Schulz, C. Engel, A.J. Niestroj, A. Kehlen, J.U. Rahfeld, M. Kleinschmidt, K. Lehmann, S. Roßner, H.U. Demuth (2014) A non-canonical function of eukaryotic elongation factor 1A1:regulation of interleukin-6 expression. Biochim Biophys Acta Mol. Cell Res. 1843, 965-975. IF:4,8

 

83. F. Kara, R. Schliebs, S. Roßner, A. Van der Lindenden, H.J.M. Groot, A. Alia (2014) Longitudinal monitoring of transverse relaxation time (T2) changes in the corpus callosum of a mouse model of Alzheimer’ disease. Neuroimage in revision.

 

84. S. K. Falsafi, S. Roßner, M. Ghafari, M. Groessl, M. Morawski, C. Gerner, G. Lubec (2014) Changes of several brain receptor complexes in the cerebral cortex of patients with Alzheimer disease: probable new potential pharmaceutical targets. Amino Acids 46 (1), 223-233. IF: 3,9

 

 

Buchkapitel

 

1. R. Schliebs and S. Roßner (1995): Distribution of muscarinic acetylcholine receptors in the CNS. In: CNS Neurotransmitters and Neuromodulators: Acetylcholine (ed. T.W. Stone), CRC Press, Boca Raton, 67-83.

 

2. R. Schliebs, S. Roßner, V. Bigl (1999) Basal forebrain cholinergic dysfunction and Alzheimer’s disease - lessons from a novel experimental approach. Recent Res. Devel. Neurochem. 2, 1-14.

 

3. S. Roßner and S. Lichtenthaler (2008) Alzheimer’s disease BACE proteases. In: Handbook of Neurochemistry and Molecular Neurobiology; Vol. 17 Developmental and Aging Changes in the Nervous System. pp 261-278. Springer, New York, USA.ISBN: 978-0-387-32670-2